Cargando…
Mesenchymal Stromal Cells in Neuroblastoma: Exploring Crosstalk and Therapeutic Implications
Neuroblastoma (NB) is the second most common solid cancer in childhood, accounting for 15% of cancer-related deaths in children. In high-risk NB patients, the majority suffers from metastasis. Despite intensive multimodal treatment, long-term survival remains <40%. The bone marrow (BM) is among t...
Autores principales: | Hochheuser, Caroline, Windt, Laurens J., Kunze, Nina Y., de Vos, Dieuwke L., Tytgat, Godelieve A.M., Voermans, Carlijn, Timmerman, Ilse |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826431/ https://www.ncbi.nlm.nih.gov/pubmed/33287630 http://dx.doi.org/10.1089/scd.2020.0142 |
Ejemplares similares
-
The Potential of Mesenchymal Stromal Cells in Neuroblastoma Therapy for Delivery of Anti-Cancer Agents and Hematopoietic Recovery
por: Hochheuser, Caroline, et al.
Publicado: (2021) -
The Metastatic Bone Marrow Niche in Neuroblastoma: Altered Phenotype and Function of Mesenchymal Stromal Cells
por: Hochheuser, Caroline, et al.
Publicado: (2020) -
A systematic review and meta-analysis of the ability of analgesic drugs to reduce metastasis in experimental cancer models
por: Hooijmans, Carlijn R., et al.
Publicado: (2015) -
Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease Panel
por: van Wezel, Esther M., et al.
Publicado: (2019) -
The Role of Reactive Oxygen Species in Mesenchymal Stem Cell Adipogenic and Osteogenic Differentiation: A Review
por: Atashi, Fatemeh, et al.
Publicado: (2015)